2WF-10329-27058
2 vaccinations
6 coded responses
14 check-ins
6 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 56-60
- ZIP prefix
- 303 / GA
- Registered
- 2021-01-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-31
Dose 1 — Moderna
-
2021-01-29
Dose 2 — Moderna
-
2021-01-30
Registered in v-safe
-
2021-01-30
Survey response — days 1–6 daily, dose 2MedDRA: Ageusia, Confusional state, Hypogeusia, Hyposmia, Parosmia — Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: Slight confusion, some decreased taste and smell (NOT Complete)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-31
Survey response — days 1–6 daily, dose 2MedDRA: Confusional state — Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesFree text: Confusion is better and sense of smell returned. This is odd and I haven't heard it reported before so hope it helps in understanding pathophysiology of this in Covid19.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-02
Survey response — days 1–6 daily, dose 2MedDRA: Anosmia — Feeling: Fair · Fatigue or tiredness, Nausea, Diarrhea · Be unable to work, Be unable to do your normal daily activitiesFree text: Sense of smell returned completely.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-03
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tiredness · Be unable to workAdult check-in
-
2021-02-04
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tiredness · Be unable to workAdult check-in
-
2021-02-05
Survey response — day 7, dose 2MedDRA: Gingival discomfort, Gingival pain — Feeling: Fair · Fatigue or tiredness · Be unable to workFree text: Wanted to note that in first few days after shot I had gingival pain and irritation I couldn't otherwise explain. Has now resolved.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-12
- 2021-02-19
- 2021-02-26
- 2021-03-05
- 2021-03-12
-
2021-05-01
Survey response — 3 months, dose 2MedDRA: Dry eye — Feeling: Fair · Be unable to work, Be unable to do your normal daily activitiesFree text: Severe dry eyes right worse than left. Mildly improved with Restaysis and punctal plugs.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-30
-
2022-01-29
Survey response — 12 months, dose 2MedDRA: Electromyogram abnormal, Peripheral sensorimotor neuropathy, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Sensorimotor Peripheral pyneuropathy....diagnosed by (b)(6). Started 2_3 months ago. Also chronic dry eye which is resistant to treatment...started in April.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-31 | Moderna | |
| 2 | 2021-01-29 | Moderna |
Free text
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Slight confusion, some decreased taste and smell (NOT Complete)
Systemic reaction (other): Confusion is better and sense of smell returned. This is odd and I haven't heard it reported before so hope it helps in understanding pathophysiology of this in Covid19.
Systemic reaction (other): Sense of smell returned completely.
Release 3 — day 7, dose 2
Systemic reaction (other): Wanted to note that in first few days after shot I had gingival pain and irritation I couldn't otherwise explain. Has now resolved.
Release 8 — 3 months, dose 2
Symptoms: Severe dry eyes right worse than left. Mildly improved with Restaysis and punctal plugs.
Release 11 — 12 months, dose 2
Symptoms: Sensorimotor Peripheral pyneuropathy....diagnosed by (b)(6). Started 2_3 months ago. Also chronic dry eye which is resistant to treatment...started in April.
redacted (b)(6)
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Dry eye | ✓ | ✓ | ✓ |
| SD | Electromyogram abnormal | · | · | ✓ |
| SD | Peripheral sensorimotor neuropathy | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SRO | Ageusia | ✓ | ✓ | ○ |
| SRO | Anosmia | ✓ | ✓ | ✓ |
| SRO | Confusional state | ✓ | ✓ | ✓ |
| SRO | Gingival discomfort | ✓ | ✓ | ✓ |
| SRO | Gingival pain | ✓ | ✓ | ✓ |
| SRO | Hypogeusia | · | · | ✓ |
| SRO | Hyposmia | · | · | ✓ |
| SRO | Parosmia | ✓ | ✓ | ○ |
✓ active code · ○ coded but marked inactive · blank = not in that release